TLK-199 (Telik).
Article Details
- CitationCopy to clipboard
Hamilton D, Batist G
TLK-199 (Telik).
IDrugs. 2005 Aug;8(8):662-9.
- PubMed ID
- 16044376 [ View in PubMed]
- Abstract
Telik Inc is developing TLK-199, an intravenous inhibitor of glutathione S-transferase P1-1, for the potential prevention of myelosuppression in blood diseases, namely myelodysplastic syndrome.
DrugBank Data that Cites this Article
- Drugs